Kwality Pharmaceuticals gets nod for Leuprorelin Acetate 11.25 mg vial powder & solvent for injectable suspension

06 Nov 2024 Evaluate

Kwality Pharmaceuticals has successfully filed and got the approval for Leuprorelin Acetate 11.25 mg vial powder and solvent for injectable suspension as a site variation in Greece, marking its entry into the European Markets. Kwality Pharma will supply the first three validation batches in December and after complete Quality Control Analysis, will start regular supplies from January 2025 onwards.

This strategic CDMO arrangement is projected to generate around $3 million of yearly sales, with distribution set to begin in the 4th quarter of this fiscal year. Furthermore, the company has plans to add remaining strengths of the same in the product portfolio with the same buyer as well. This marks a pivotal step in its strategy to introduce products in highly regulated markets.  

Kwality Pharmaceuticals (formerly Kwality Pharmaceuticals) is a pharmaceutical formation company.


Kwality Pharma Share Price

899.15 27.80 (3.19%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×